Imago BioSciences, Inc. clinical trials
Acquired by Merck & Co., Inc, Jan 11, 2023 · source ↗
The registry lists 5 studies whose lead sponsor is Imago BioSciences, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 7, 2026.
Before and after it joined Merck & Co., Inc
- First submitted before Imago BioSciences, Inc. became part of Merck & Co., Inc
- 5
- First submitted after Imago BioSciences, Inc. became part of Merck & Co., Inc
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Status
- Completed
- 5
Registry sponsor names on this page
- Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)5 studies
Something wrong with this grouping? Tell us on the Merck & Co., Inc page.
Studies
Recruiting first, then most recently updated. Showing 5 of 5. All Merck & Co., Inc studies →
- A Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Polycythemia Vera (IMG-7289-CTP-203/MK-3543-004)CompletedNCT05558696Phase 2
Sponsor listed in the registry: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) · First submitted before Imago BioSciences, Inc. became part of Merck & Co., Inc
- Study of Bomedemstat in Participants With Essential Thrombocythemia (IMG-7289-CTP-201/MK-3543-003)CompletedNCT04254978Phase 2
Sponsor listed in the registry: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) · First submitted before Imago BioSciences, Inc. became part of Merck & Co., Inc
- An Extension Study of Bomedemstat (IMG-7289/MK-3543) in Participants With Myeloproliferative Neoplasms (IMG-7289-CTP-202/MK-3543-005)CompletedNCT05223920Phase 2
Sponsor listed in the registry: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) · First submitted before Imago BioSciences, Inc. became part of Merck & Co., Inc
- Bomedemstat (IMG-7289/MK-3543) in Participants With Myelofibrosis (IMG-7289-CTP-102/MK-3543-002)CompletedNCT03136185Phase 1/2
Sponsor listed in the registry: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) · First submitted before Imago BioSciences, Inc. became part of Merck & Co., Inc
- A Study of Bomedemstat (IMG-7289/MK-3543) With and Without ATRA, in Participants With Advanced Myeloid Malignancies (IMG-7289-CTP-101/MK-3543-001)CompletedNCT02842827Phase 1/2
Sponsor listed in the registry: Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) · First submitted before Imago BioSciences, Inc. became part of Merck & Co., Inc